Stay updated on Pembrolizumab in Refractory Meningioma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Refractory Meningioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Refractory Meningioma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    - Added a government funding notice with operational details and links; - Updated version to v3.2.0; - Removed reference to v3.1.0.
    Difference
    3%
    Check dated 2025-10-06T04:57:09.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    Update indicates a new software release (v3.1.0) replacing the previous v3.0.2—no other substantive content changes are shown.
    Difference
    0.1%
    Check dated 2025-09-29T02:57:26.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2. The 'Back to Top' link was removed.
    Difference
    0.2%
    Check dated 2025-09-14T18:57:48.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.
    Difference
    0.2%
    Check dated 2025-09-07T14:24:20.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location in Petah Tikva, Israel, while also removing various related terms and resources, including previous mentions of pembrolizumab and other medical classifications.
    Difference
    2%
    Check dated 2025-08-31T11:42:48.000Z thumbnail image
  8. Check
    60 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.11 to v2.16.12.
    Difference
    0.2%
    Check dated 2025-08-17T01:47:08.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Refractory Meningioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Refractory Meningioma Clinical Trial page.